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ABSTRACT We describe a deep-sequencing procedure for tracking large numbers of transposon mutants of Pseudomonas aerugi-
nosa.TheprocedureemploysanewTn-seqmethodologybasedonthegenerationandampliﬁcationofsingle-strandcirclescar-
ryingtransposonjunctionsequences(theTn-seqcirclemethod),amethodwhichcanbeusedwithvirtuallyanytransposon.The
procedurereliablyidentiﬁedmorethan100,000transposoninsertionsinasingleexperiment,providingnear-saturationcover-
ageofthegenome.Totesttheeffectivenessoftheprocedureformutantidentiﬁcation,wescreenedformutationsreducingin-
trinsicresistancetotheaminoglycosideantibiotictobramycin.Intrinsictobramycinresistancehadbeenpreviouslyanalyzedat
genomescaleusingmutant-by-mutantscreeningandthusprovidedabenchmarkforevaluatingthenewmethod.ThenewTn-
seqprocedureidentiﬁed117tobramycinresistancegenes,themajorityofwhichwerethenveriﬁedwithindividualmutants.The
groupofgeneswiththestrongestmutantphenotypesincludednearlyall(13of14)ofthosewithstrongmutantphenotypesiden-
tiﬁedinthepreviousscreening,aswellasanearlyequalnumberofnewgenes.TheresultsthusshowtheeffectivenessoftheTn-
seqmethodindeﬁningthegeneticbasisofacomplexresistancetraitof P.aeruginosaandindicatethatitcanbeusedtoanalyzea
varietyofgrowth-relatedprocesses.
IMPORTANCE Researchprogressinmicrobiologyistechnologylimitedinthesensethattheanalyticalmethodsavailabledictate
howquestionsareexperimentallyaddressedand,tosomeextent,whatquestionsareasked.Thisreportdescribesanewtranspo-
sontrackingprocedurefordeﬁningthegeneticbasisofgrowth-relatedprocessesinbacteria.Themethodemploysnext-
generationsequencingtomonitorthemakeupofmutantpopulations(Tn-seq)andhasseveralpotentialadvantagesoverother
Tn-seqmethodologies.Thenewmethodwasvalidatedthroughtheanalysisofaclinicallyrelevantantibioticresistancetraitin
Pseudomonas aeruginosa, an important bacterial pathogen.
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T
he process of deﬁning the genetic basis of complex bacterial
traits using mutant hunts has been greatly accelerated by the
developmentoftechnologiesfortrackingindividualstrainsinsat-
urationlevelmixturesoftransposonmutants.Severalsuchproce-
dures based on next-generation DNA sequencing have recently
beendescribed(1–4).Themethods,referredtocollectivelyhereas
Tn-seq(4),providedramaticimprovementsinthespeciﬁcityand
dynamic range of mutant detection over techniques for tracking
transposon mutants based on PCR or microarray hybridization.
TheTn-seqprocedureshaveemployedseveralmethodstocapture
and sequence transposon-genome junctions, including afﬁnity
puriﬁcation of ampliﬁed junctions (1), ligation of adaptors into
genome sequences distal to the transposon end with the aid of a
specialized restriction site (2, 4), and selective ampliﬁcation (3).
Tn-seq has been used to characterize a variety of traits in several
species,namely,pulmonarycolonizationinHaemophilusinﬂuen-
zae (1), in vivo ﬁtness in the gut symbiont Bacteroides thetaio-
taomicron (2), mutant interactions in Streptococcus pneumoniae
(4),andbiletolerancegenesinSalmonellaenterica(3).Inthework
describedhere,wedevelopedanewTn-seqtechnologyandusedit
to examine an antibiotic resistance trait in Pseudomonas aerugi-
nosa.
The Gram-negative opportunistic pathogen P. aeruginosa ex-
hibits unusually high intrinsic resistance to antibiotics and other
toxic substances, properties which greatly limit the therapeutic
options available to treat infections (5). The functions mediating
resistance represent potential drug targets, since their inhibition
couldenhancetheefﬁcacyofantibioticsincombinationtherapies
(6, 7). Intrinsic antibiotic resistance traits of P. aeruginosa and
other Gram-negative species are complex, typically controlled by
dozens of gene products, including efﬂux pumps, modifying en-
zymes,andelementsofgeneralstressresponses.Forexample,ina
genome-wide study of tobramycin resistance in P. aeruginosa,w e
identiﬁed mutations in over 100 genes that reduced intrinsic re-
sistance to the antibiotic (7). The genes were identiﬁed by screen-
ing the members of a comprehensive, deﬁned transposon mutant
library one by one. The genes identiﬁed included several involved
in a novel envelope stress response pathway which may help pro-
tect cells from tobramycin-induced mistranslation products
which disrupt the membrane (7). In the study reported here, we
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validate the newly developed Tn-seq method of mutant identiﬁ-
cation.
RESULTS
A new Tn-seq methodology. Using deep sequencing to track in-
sertionmutants(Tn-seq)requirestheselectivesequencingoffrag-
ments which bear transposon-genome junctions. Three different
methods for doing this have recently been described, all based on
Illuminasequencing(1–4).Weindependentlydevelopedafourth
method, based on the generation of single-stranded DNA circles
that carry transposon junctions, called the “circle method”
(Fig. 1). The circles are protected from an exonuclease treatment
whicheliminatesmostgenomicDNA,andtheythenserveastem-
plates for quantitative ampliﬁcation and sequencing of the junc-
tions. The junction sequences are used to map the corresponding
insertions in the genome of the mutagenized strain.
UseofTn-seqtoproﬁlepoolsofP.aeruginosainsertionmu-
tants. In a ﬁrst test, we analyzed a pool of P. aeruginosa PAO1
mutants derived from a larger library (8) which included 3,625
strains with transposon insertions which had been mapped and
conﬁrmed by sequencing. The Tn-seq circle method identiﬁed
99.3% of these insertion locations (not shown), illustrating the
effectiveness of the procedure. The result encouraged us to exam-
ine the performance of the procedure in proﬁling a much larger
mutant pool.
Forthesecondtest,wecreatedapoolofapproximately100,000
undeﬁned ISlacZ/hah insertion mutants (nearly 20 insertions per
gene), isolated DNA from the pool, and analyzed it in two inde-
pendent Tn-seq runs. From the two technical replicates, 95,905
unique insertion locations were identiﬁed, in good agreement
with the number of mutants pooled (Table 1). Approximately
91% of the unique insertion sites identiﬁed in each replicate were
alsoidentiﬁedintheotherreplicate,suggestingthattheprocedure
primarily identiﬁed authentic insertion locations. Additional Tn-
seq analysis of the same transposon mutant pool (Table 1) found
that about 99% of the locations identiﬁed were detected in multi-
ple Tn-seq runs and were thus presumably authentic. We assume
that the irreproducible sites (about 1% of the total in each Tn-seq
run) correspond to spurious ampliﬁcation products. For subse-
quent analysis, we therefore included only locations that were de-
tected in multiple independent Tn-seq runs (Table 1).
The number of sequence reads per individual location varied
somewhat between technical replicates, but the total numbers of
reads at all locations within each gene were highly correlated
(Fig. 2A). The Tn-seq circle method thus appears to provide a
reproducible and quantiﬁable readout of mutant representation
at the gene level.
Identiﬁcation of genes required for tobramycin resistance.
To examine whether the Tn-seq circle method could effectively
identify genes required for a growth trait, we examined intrinsic
resistance to tobramycin. Numerous genes associated with the
trait are known (7), providing a reference set to help evaluate the
new method. We grew the pool of 100,000 mutants characterized
aboveinthepresenceorabsenceofasubinhibitoryconcentration
of tobramycin (about one-half of the MIC) and used Tn-seq to
determine which mutants were selectively lost in the treated cul-
ture. The selection and Tn-seq analysis were carried out twice,
withhighlyreproducibleresults(Fig.2BandC).Mutationsaffect-
ing numerous candidate resistance genes were selectively lost in
the presence of tobramycin (Fig. 2D).
Lossofmutantsinthepresenceoftobramycinwasrepresented
for each gene as the ratio of total mutant sequence reads with and
without the antibiotic, with both biological replicates included
(seeTableS1inthesupplementalmaterial).Readscorresponding
to the 5= and 3= 10% of each open reading frame (ORF) were
excludedtohelpeliminateinsertionswhichwerenotinactivating,
and the numbers of reads were normalized for gene length, total
mapped reads in the corresponding Tn-seq run, and local read
density(seeMaterialsandMethods).Geneswithveryfewmapped
insertion locations or which showed a signiﬁcant loss of mutant
representation after growth in the absence of tobramycin were
also excluded (see Materials and Methods). By these criteria, 117
genesshowedgreaterthan2.5-foldnegativeselection(Fig.2D;see
TableS1inthesupplementalmaterial),with29ofthemexhibiting
10-fold or greater negative selection. Several examples of genes
exhibitingstrongnegativeselectioninthepresenceoftobramycin
illustrate the loss of sequence reads relative to neighboring genes
in which mutations were not negatively selected (Fig. 3).
The 117 negatively selected genes included 13 of the 14 genes
identiﬁed in the previous mutant-by-mutant screening as con-
tributing strongly to tobramycin resistance (7) (Fig. 2D). The
missing gene, PA4961, had been excluded because of very low
Tn-seq representation after growth without tobramycin. The re-
sults show that the Tn-seq approach was relatively effective in
identifying the known resistance functions.
Veriﬁcation of sensitivity phenotypes using individual mu-
tants.Ofthe117genesassociatedwithintrinsictobramycinresis-
tancebyTn-seq,24hadbeenpreviouslycharacterizedusingindi-
vidual mutants (7). To test sensitivity phenotypes for newly
identiﬁed genes, we recovered individual transposon mutants
from the PAO1 mutant library (8) or constructed deletion mu-
tants.
Transposonmutantscorrespondingto58ofthe93newlyiden-
tiﬁed tobramycin resistance genes were assayed, with at least two
differentmutantallelestestedformost(42/58)(seeTableS1inthe
supplemental material). Each of the mutants was single colony
puriﬁed and resequenced to conﬁrm its identity prior to assaying
sensitivity. Mutations in 47 of the 58 genes increased tobramycin
sensitivitybyMICassay(seeTableS1).Thesensitivityphenotypes
of 35 of the 47 were conﬁrmed using multiple mutants.
For several of the tobramycin resistance genes identiﬁed by
Tn-seq, there were either no (or few) transposon mutants avail-
ableinthePAO1library,theonlymutantsavailablecorresponded
to in-frame lacZ or phoA fusions (possibly causing sensitivity by a
gain-of-function mechanism) (7), or different mutant alleles led
to different tobramycin sensitivities. For seven such genes in the
group displaying 10-fold or greater negative selection by Tn-seq,
we created deletion mutants and examined their tobramycin sen-
sitivities by MIC assays. All seven deletions increased tobramycin
sensitivity (see Table S1 in the supplemental material).
Overall, of the 117 tobramycin resistance genes identiﬁed by
Tn-seq, 85 were tested by assays of individual mutants in this and
thepreviousstudyand74(87%)wereconﬁrmedtodisplayatleast
a 2-fold decrease in the tobramycin MIC. The conﬁrmed group
includednearlyall(26/27)ofthegeneswiththestrongestnegative
selection (10-fold or greater) identiﬁed by Tn-seq.
Mutations in 28 genes led to at least 4-fold decreases in the
tobramycin MIC (Table 2). This group included 13 previously
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cation with individual mutants is illustrated by the fact that some
of the mutations leading to large reductions in the tobramycin
MIC were not in the top group negatively selected in the Tn-seq
experiments (Table 2). Nevertheless, there was a correlation be-
tween the magnitude of the negative selection in the Tn-seq anal-
ysis and the MICs of the corresponding individual mutants
(Fig. 4).
DISCUSSION
This report describes the development and validation of a proce-
dure to identify the genetic basis of growth-related traits in bacte-
ria. The procedure (the Tn-seq circle method) employs second-
generation DNA sequencing to track changes in the makeup of
saturation-level pools of transposon mutants grown under selec-
tion. The procedure was validated by the analysis of intrinsic
P.aeruginosaresistancetotheaminoglycosideantibiotictobramy-
cin, a trait which had been analyzed previously by genome-scale
mutant-by-mutant screening (7). The new procedure identiﬁed
both the most signiﬁcant tobramycin resistance genes established
in the previous study and a number of new genes.
The Tn-seq circle method differs from several other proce-
dures employing deep sequencing to track transposon mutants in
that it employs a single-strand circularization step to selectively
protecttransposon-genomejunctionfragmentsfromexonuclease
degradation prior to ampliﬁcation and sequencing. Other meth-
ods enrich for junction fragment sequences by employing a Mar-
iner transposon carrying an MmeI restriction site at one or both
endstoallowtheadditionofadaptorstogenomesequences16bp
fromthejunction(2,4)byselectiveampliﬁcationfollowingDNA
fragmentation and adaptor ligation using a transposon-speciﬁc
primer alone (3) or followed by afﬁnity puriﬁcation of ampliﬁed
junctions (1). The method we developed has several potential ad-
vantages. First, it does not require the use of a speciﬁc transposon
carrying an MmeI site. Rather, the presence of a recognition site
for almost any 6- or 8-bp cutter near (within ~500 bp) either
transposon end is sufﬁcient; it can thus be used with most trans-
posons. This versatility may be particularly valuable for the anal-
ysis of bacteria like P. aeruginosa with GC-rich DNA, since Mari-
ner requires a TA sequence at its insertion sites. Second, our
method yields a high proportion of sequence reads from
transposon-genome junctions. In most assays, approximately
90% of the reads mapped to the PAO1 genome and greater than
98%ofthemappedpositionsappearedtobeauthentictransposon
insertion locations (Table 1). By comparison, at most 67% of the
reads from the selective ampliﬁcation method bore transposon-
identifying tags and mapped to the target genome (3). For the
afﬁnity puriﬁcation method (1), the proportion of mapped reads
was not reported, but the total number of reads which mapped to
nonrepetitivechromosomalregionswasabout15-foldlowerthan
thatobtainedbythecirclemethod.Thenucleolyticeliminationof
unwanted genome sequences in the Tn-seq circle method may
reducethebackgroundofirrelevantsequencereadsrelativetothe
other methods. A direct comparison of the different methods us-
ing common test samples should help reveal their relative merits
more deﬁnitively.
For genes identiﬁed through genomic-scale mutant screens,
validation of phenotypes using individual mutants is generally a
limiting step (9, 10). However, studies with P. aeruginosa beneﬁt
from the availability of near-saturation deﬁned transposon mu-
FIG1 Tn-seqcirclemethod.Thestepsusedtoamplifyandsequencetransposon
insertion junctions are illustrated, beginning with a DNA fragment carrying a
transposon insertion (top). First, total DNA from a mutant pool is sheared and
endrepaired,andoneIlluminaadaptor(A2)isligatedtoallfreeends(step1).The
sample is then digested with a restriction enzyme that cuts near one transposon
end(inthiswork,BamHI,whichcuts114bpfromthetransposon’sleftend)(step
2).Followingasizeselectionstep,single-strandfragmentswhichincludethetrans-
poson end are circularized by templated ligation (step 3). Oligo, oligonucleotide.
Fragments which have not circularized (representing most of the DNA in the
sample) are degraded in a subsequent exonuclease step (step 4). The transposon-
genome junctions from the circularized fragments are then ampliﬁed by quanti-
tative PCR in a step in which the second required Illumina adaptor (A1) is intro-
duced (step 5). The products are sequenced on an Illumina ﬂow cell using a
sequencingprimercorrespondingtothetransposonend(Seq),andeachsequence
read is then mapped to the genome (step 6).
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trieved and tested (8, 11). Thus, in this study, we assayed the to-
bramycin sensitivity of individual insertion mutants affected in
more than half (50) of the genes newly identiﬁed using Tn-seq.
Formostofthegenes,twoormorediffer-
ent mutants were assayed to provide con-
ﬁrmation of phenotypes. In several cases,
we also created and tested deletion mu-
tants. Altogether, of 117 intrinsic resis-
tance genes identiﬁed by Tn-seq, 85 were
examined in this and the previous study
(7) and 74 of the 85 were found to de-
crease the tobramycin MIC.
We observed only a partial correlation
between mutant loss from the pool ex-
posedtotobramycinandtheMICchange
observed in assays of individual strains
(Fig. 4). For example, there were striking
cases of strong negative selection in the
pool-based screens which were not re-
ﬂected in correspondingly large MIC
changes with individual mutants (e.g.,
PA2656inFig.3B;seeTableS1inthesup-
plemental material). The result suggests
that there may have been undeﬁned dif-
ferences in the selective pressures under
the two assay conditions. However, at-
tempts to show altered sensitivities for
speciﬁc mutants when mixed with excess
wild-type cells were not successful (data
not shown). Overall, the ﬁndings illus-
tratetheimportanceoflarge-scalevalida-
tion of Tn-seq results using individual
strains to identify the subsets of mutants
with the strongest phenotypes.
These studies identiﬁed several new
tobramycin resistance functions whose
inactivation greatly increased sensitivity,
including PA1805 (ppiD), PA4077, and
PA0392 (Table 2). PA1805 encodes a
peptidyl-prolyl cis-trans isomerase and is
thought to facilitate the folding of mem-
brane and exported proteins (12–14).
Since misfolded proteins resulting from
aminoglycoside-induced translation er-
rors are thought to compromise the
membrane barrier and contribute to bac-
terialkilling(7),thelossoffunctionspro-
moting proper folding may enhance sen-
TABLE 1 Tn-seq analysis of P. aeruginosaa
Growth condition Total no. of reads No. (%) of mapped reads No. of locations identiﬁed No. (%) of authentic locationsb
Initial poolc 19,778,278 15,739,802 (80) 95,905 94,531 (98.6)
Trial 1
Without tobramycin 14,152,566 12,601,670 (89) 96,745 96,185 (99.4)
With tobramycin 10,699,404 9,691,469 (91) 76,474 76,109 (99.5)
Trial 2
Without tobramycin 12,660,378 11,081,531 (88) 99,580 98,258 (98.7)
With tobramycin 12,041,290 10,799,523 (90) 98,243 96,925 (98.7)
a A pool of approximately 100,000 independent transposon mutants was analyzed by the Tn-seq circle method after growth under different conditions.
b Authentic locations were deﬁned as those identiﬁed in multiple Tn-seq assays of samples derived from the transposon mutant pool.
c The values for the initial pool represent two replicate assays of a single DNA preparation.
FIG2 IdentiﬁcationofinsertionmutantsusingTn-seq.PairsofTn-seqassayresultsarecompared,withthe
total number of reads per gene plotted. (A) Replicate Tn-seq analysis of a single DNA sample isolated from
the 100,000-member transposon mutant pool. The total numbers of reads for genes were highly correlated
(Pearson correlation coefﬁcient  87%). (B) Replicate analysis of DNA samples corresponding to two
cultures of the 100,000-member mutant pool grown in the absence of tobramycin (Tob) (correlation coef-
ﬁcient  80%). (C) Replicate analysis of DNA samples corresponding to two cultures of the mutant pool
growninthepresenceofasubinhibitorytobramycinconcentration(0.36g/ml)(correlationcoefﬁcient
71%).(D)Comparisonofthegrowthofthemutantpoolwithouttobramycintoitsgrowthwithtobramycin.
Valuesrepresentaveragenumbersofreadspergenefromthepairsofbiologicalreplicates(panelsBandC).
Red points represent genes for which mutants were previously identiﬁed as being strongly tobramycin
hypersensitive (7). The diagonal lines represent the thresholds for 2.5-fold and 10-fold negative selection,
respectively. Points on the axes in panels B and C reﬂect genes represented in only one of the two biological
replicates. In almost all cases, these represent genes with very few (fewer than three) total insertions. Most
(79%)ofthesegeneswereexcludedfromtheanalysisofnegativeselectionbecauseofthelowrepresentation
(seeMaterialsandMethods).ReadcountspergenewerecalculatedandnormalizedasdescribedinMaterials
and Methods, except for panel A, in which insertions at all positions within each gene were included and
values were not normalized for gene length.
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putative peptidyl-prolyl isomerases
(PA1996andPA1800)alsoincreasedsen-
sitivity to tobramycin (see Table S1 in the
supplemental material).
Several new transcriptional regulators
also contributed to intrinsic tobramycin
resistance,includingPA4077andPA0762
(algU),implyingarelativelycomplexreg-
ulation of aminoglycoside resistance.
PA0762 (algU) encodes a homologue of a
sigmafactor(E)thatregulatesanimpor-
tant envelope stress response in Esche-
richia coli (14–16), and mutations inacti-
vating another component of this
pathway (PA3649, mucP) also increased
tobramycin sensitivity. We assume that,
like peptidyl-prolyl isomerases, stress re-
sponsefunctionscontrolledbyAlgUcon-
tribute to intrinsic resistance by helping
cells tolerate misfolded or aberrant mem-
FIG3 Examples of negative selection revealed by Tn-seq. The graphs show the number of Tn-seq reads at
each location from the sample prior to growth, after growth without tobramycin (Tob), and after growth
withasubinhibitoryconcentrationoftobramycin.Dataareaveragedfrombiologicalreplicatesandnormal-
ized as described in Materials and Methods. Regions of the genome corresponding to 8,000 bp are shown,
withthepredictedgenesrepresentedatthebottomofeachpanel.(A)TheamgRSregion.Insertionsinboth
amgRandamgSareselectedagainststronglyinthepresenceoftobramycin,whereasinsertionsinPA5198are
selected against whether or not tobramycin is present. (B) The PA2656 region. The graphs show strong
negative selection of PA2656 mutants in the presence of tobramycin. PA2656 encodes a two-component
regulator implicated in intrinsic tobramycin resistance by these results.
TABLE 2 Genes identiﬁed by Tn-seq exhibiting strong mutant hypersensitivity to tobramycina
Locus Gene Function
No. of normalized reads
(no. of hits with reads)b
Selection
ratiob
Previously
identiﬁedc
No. of
mutants
testedd MICe Pregrowth Growth without Tob Growth with Tob
None (PAO1) 1.0
PA3303 (control) 1,888 (17) 2,062 (20) 1,703 (20) 0.83 1 1.0
PA0392 Conserved hypothetical 644 (5) 1,374 (5) 0 (0) 0 No 2f 0.25
PA4077 Transcriptional regulator 1,572 (3) 1,230 (3) 0 (0) 0 No 1f 0.25
PA5199 amgS Two-component sensor 764 (18) 663 (20) 0 (0) 0 Yes 0.125
PA5366 pstB Phosphate transport 1,748 (8) 761 (8) 0 (0) 0 Yes 0.25
PA5200 amgR Two-component response regulator 752 (9) 396 (12) 2 (1) 0.00 Yes 0.063
PA0016 trkA Potassium uptake 1,089 (16) 823 (16) 5 (2) 0.01 Yes 0.25
PA4942 hﬂK Protease subunit 2,436 (14) 2,104 (16) 30 (2) 0.01 Yes 0.25
PA3014 faoA Fatty acid oxidation 1,465 (23) 1,227 (27) 56 (5) 0.05 No 5 0.25
PA4398 Two-component sensor 862 (19) 633 (19) 30 (2) 0.05 Yes 0.25
PA5528 Hypothetical 2,363 (12) 2,839 (13) 161 (4) 0.06 Yes 0.125
PA1805 ppiD Peptidyl-prolyl isomerase 3,920 (29) 4,583 (29) 397 (12) 0.09 No 5 0.25
PA3016 Hypothetical 1,630 (9) 840 (8) 87 (1) 0.10 Yes 0.125
PA4223 Transport 638 (19) 790 (19) 106 (10) 0.13 No 3 0.25
PA4960 Amino acid metabolism 916 (15) 507 (17) 80 (2) 0.16 No 2 0.25
PA0374 ftsE Cell division 4,583 (8) 4,366 (8) 705 (4) 0.16 No 3 0.125g
PA3013 foaB Fatty acid oxidation 3,632 (29) 2,925 (32) 485 (14) 0.17 Yes 0.25
PA5471 Hypothetical 655 (8) 755 (8) 129 (4) 0.17 Yes 0.25
PA0502 Biotin biosynthesis 1,131 (9) 627 (9) 108 (3) 0.17 No 1 0.25
PA3194 edd Carbohydrate metabolism 253 (10) 161 (11) 29 (5) 0.18 No 1 0.125
PA1775 cmpX Cytoplasmic membrane protein 1,670 (13) 747 (11) 134 (7) 0.18 No 3 0.25
PA0427 oprM Multidrug efﬂux 1,877 (15) 1,427 (15) 298 (6) 0.21 Yes 0.25
PA4222 Transport 551 (16) 333 (18) 74 (6) 0.22 No 2 0.25
PA5369 pstS Phosphate transport 1,037 (10) 631 (9) 164 (3) 0.26 No 3 0.25g
PA2018 mexY Multidrug efﬂux 3,025 (45) 2,761 (46) 811 (40) 0.29 Yes 0.25
PA5285 Hypothetical 1,293 (4) 1,559 (4) 466 (4) 0.30 No 4 0.25
PA2604 Conserved hypothetical 2,736 (8) 2,162 (9) 649 (8) 0.30 No 3 0.25
PA2019 mexX Multidrug efﬂux 2,403 (20) 2,488 (21) 930 (18) 0.37 Yes 0.25
PA4050 pgpA Phospholipid biosynthesis 1,931 (6) 1,214 (7) 483 (4) 0.40 No 3 0.125
a Genes whose mutation caused a 4-fold or greater MIC change are listed.
b See text for method of calculation. Tob, tobramycin.
c Reference 7.
d Number of independent mutants tested. Thirty-four of the 42 mutants examined were conﬁrmed by resequencing, including at least one representative for each gene.
e MIC values (in micrograms per milliliter) for representative mutants as measured in this study or in reference 7.
f Includes one deletion mutant.
g Phenotype possibly due to expression of hybrid proteins.
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with other envelope-protective responses, including the AmgRS
response (7), may account for the relatively modest increase in
sensitivity which accompanies the inactivation of algU (see Ta-
ble S1 in the supplemental material).
PA0392 encodes a conserved cytoplasmic membrane protein
of unknown function. The E. coli ortholog of PA0392 (yggT) con-
tributes to osmotic stress tolerance when potassium uptake is re-
duced (17). Since inactivating either of two genes of the Trk po-
tassium uptake system (trkA and trkH) also increases tobramycin
sensitivity in P. aeruginosa (see Table S1 in the supplemental ma-
terial and reference 7), it is possible that PA0392 contributes to
intrinsic resistance by promoting potassium homeostasis.
Insummary,wehavepresentedevidencethatacombinationof
a new Tn-seq screening method and large-scale veriﬁcation with
individual mutants is an effective procedure for identifying the
genes responsible for an intrinsic resistance trait in P. aeruginosa.
Theapproachshouldfacilitatethegeneticdissectionofavarietyof
growth-related processes in P. aeruginosa and other prokaryotes
for which transposon mutagenesis is possible.
MATERIALS AND METHODS
Strains, media, and MIC assays. The P. aeruginosa strain used was
MPAO1 (18). E. coli SM10pir bearing plasmid pIT2 (8) was used as a
donor for transposon T8 (ISlacZhah-tc) mutagenesis. Insertion mutants
used for validation tests were obtained from a deﬁned mutant library (8).
In-framedeletionmutantsweregeneratedbyampliﬁcationandjoiningof
~800-bp regions ﬂanking each deletion, followed by recombination into
MPAO1 using a pEX19Tc derivative carrying the deletion allele (7, 19).
Thesequencesoftheprimersusedforcreating
the deletions are listed in Table S2 in the sup-
plemental material. Growth media included
LB (10 g/liter tryptone, 5 g/liter yeast extract,
8 g/liter NaCl) and TYE (10 g/liter tryptone,
5 g/liter yeast extract, 8 g/liter NaCl, 15 g/liter
agar). MIC assays were performed as previ-
ously described (7).
Mutant pool. To create the ~100,000-
member undeﬁned transposon mutant pool,
MPAO1 was mutagenized with the Tn5-based
transposon T8 (ISlacZhah-tc) by conjugation
as previously described (8). Mutagenesis reac-
tionmixtureswerefrozeninaliquotsandlater
thawed and plated on 2 TYE agar (1 salt)
with 60 g/ml tetracycline (to select for inser-
tion mutants) and 10 g/ml chloramphenicol
(to select against the E. coli conjugal donor) in
QTrays (Genetix) at a density appropriate to
obtain 15,000 to 20,000 insertion mutant col-
onies per QTray. After incubation for 25 h at
37°C, the colonies in each QTray were col-
lected into 30 ml LB with 5% dimethyl sulfox-
ide, frozen rapidly by immersion in ethanol
and dry ice, and then stored at 80°C. Equal
volumes of the pools from seven QTrays were
later combined to create the ﬁnal pool, con-
taining approximately 105 unique strains. The
pool was frozen rapidly in aliquots and stored
at 80°C. A portion was used for DNA isola-
tion as the “pregrowth” sample (Qiagen
DNeasy Blood & Tissue Kit).
Negative selection. To carry out selection
againsttobramycin-hypersensitivestrains,ap-
proximately 4  107 CFU from the complex
mutantpoolwereplatedonTYE(solidiﬁedwith1.5%agarose)inQTrays
with either no antibiotic or 0.36 g/ml tobramycin (Sigma-Aldrich) and
incubated at 37°C for seven to nine doublings (6.5 to 9 h). Preliminary
experiments showed that growth for 7 to 10 generations on solid media
with a subinhibitory concentration of tobramycin provided robust nega-
tive selection, whereas growth for 16 or more generations substantially
diminished the complexity of the pool. The level of tobramycin (about
half of the MIC) was chosen in order to identify mutants with even weak
tobramycin sensitivity phenotypes. Following incubation, the cells were
collected into LB and DNA was isolated (Qiagen DNeasy Blood & Tissue
Kit). The total numbers of CFU in the inoculating and harvested cultures
were determined by serial dilution and plating. Selection (with and with-
out tobramycin) was carried out twice independently.
Tn-seq circle method. The procedure depicted in Fig. 1 was carried
out as follows. Six to 10 g of DNA was sheared to an average fragment
lengthof400bpusingaCovarisE210(a10%dutycycle,anintensityof5,
200 cycles per burst, and a duration of 100 s per tube) or a Bioruptor
(Diagenode)(twotubeseachwith300lDNAinTE,seven15-mintreat-
ments, setting H). If the total volume of sheared DNA exceeded ~200 l,
it was concentrated with a QIAquick PCR puriﬁcation kit (Qiagen).
Sheared DNA was end repaired using either an End-It DNA End-Repair
kit (Epicenter) or a NEBNext End Repair Module (NEB). The DNA was
then puriﬁed using a QIAquick PCR puriﬁcation kit (two columns per
sample, elution with 91 l of elution buffer [EB] per column, eluates
combined after elution). A-tailing was carried out by incubating the end-
repaired DNA for 20 min at 70°C in four 50-l reaction mixtures each
containing DNA with 1 PCR buffer with magnesium (Ambion),
0.5mMdATP,and0.25lTaq(Ambion).TheDNAwaspuriﬁedusinga
MinElute PCR puriﬁcation kit (Qiagen) (one column per A-tail reaction
mixture,elutionwith12.5lEBpercolumn,eluatescombined).Illumina
FIG 4 Tobramycin sensitivities of individual mutants of genes identiﬁed by Tn-seq. The negative
selection classes corresponding to genes showing different mutant tobramycin MIC reductions are
shown. Mutants include insertion and deletion strains tested in this and a previous study (7). The
Tn-seqnegativeselectionclassesarestrong(10-folddepleted),moderate(5-foldto10-folddepleted),
and weak (2.5-fold to 5-fold depleted).
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(NEB)anda20-foldmolarexcessofadaptorrelativetotheDNAfragment
concentration (calculated based on NanoDrop measurement and pre-
dictedaveragefragmentlength).DNAwaspuriﬁedusingaMinElutePCR
puriﬁcation kit (three columns per sample, eluates combined). The DNA
wasthendigestedovernightat37°CwithBamHI(NEB).Fragmentsof200
to 400 bp were size selected by cutting from a precast 6% acrylamide TBE
gel(Invitrogen),andtheDNAwasextractedfromthecrushedgelslicesby
incubation in TE at 65°C for several hours with periodic vortexing, fol-
lowed by ﬁltration using 0.2-m Nanosep columns (Pall/VWR) and eth-
anol precipitation. DNA was resuspended in 10 to 30 l of EB (Qiagen),
and the concentration was measured by ﬂuorometry or NanoDrop. Typ-
ical concentrations were 20 to 150 ng/l. The steps described above re-
ﬂect, with minor modiﬁcations, standard preparatory steps commonly
used for Illumina sequencing.
The circularization and exonuclease steps were based on a protocol
developed for selective and speciﬁc multiplex ampliﬁcation of nucleic
acids (20). The circularization reaction mixture, which included the size-
selected DNA (1 to 4 pmol), an approximately 10-fold molar excess of
collector probe (T8_COLLECT_1; see Table S2 in the supplemental ma-
terial), 1 Ampligase buffer, and 0.5 l Ampligase (Epicenter) in a 15-l
total reaction mixture volume, was cycled as follows: 95°C for 30 s, 15
cycles of 95°C for 30 s and 67°C for 3 min, 95°C for 2 min, and cooling to
10°C.Followingthermocycling,amixtureofexonucleases(0.5lExonu-
clease I [NEB, 20 U/l], 0.75 l LambdaExo [NEB, 5 U/l], 0.75 lT 7
Gene 6 Exonuclease [USB, 50 U/l]) was added and the sample was in-
cubatedat37°Cfor4handthenat85°Cfor20min.TheDNAwaspuriﬁed
using a MinElute PCR puriﬁcation kit (one column per sample; elution
with11.5lEB).Ampliﬁcationoftransposon-genomejunctionsfromthe
circularized fragments was carried out by real-time PCR using iTaq Su-
permixSBRGwithROX(Bio-Rad)in50-lreactionmixturescontaining
3 l of the puriﬁed DNA sample as the template and 250 nM each ampli-
ﬁcation primer (T8-SLXA_FOR_AMP2 and SLXA_REV_AMP; see Ta-
bleS2),andcyclingwasasfollows:95°Cfor2h30minandthen35cycles
of 95°C for 25 s, 59°C for 25 s, and 72°C for 30 s. After an initial test
reactiontodeterminetheoptimalnumberofcycles,thePCRwasrepeated
and stopped at a cycle corresponding to approximately 50% maximum
ampliﬁcation (usually 24 to 26 cycles). The DNA was puriﬁed with a
MinElute PCR puriﬁcation kit (elution with 10 l EB) and examined by
gel electrophoresis to conﬁrm the expected size range (controls were car-
ried out for most samples which included a reaction mixture without the
collector probe, a reaction mixture without Ampligase, and a reaction
mixture without exonucleases). The samples were sequenced by standard
Illumina sequencing (36-bp single-end runs) using sequencing primer
T8-SEQ_STA or T8-SEQ_G (see Table S2 in the supplemental material).
To optimize the efﬁciency of the circularization step, we initially var-
iedseveralparameters.Forthesetests,theamountofcircularizedproduct
in each sample following the exonuclease step was determined by quanti-
tative PCR using primers designed to amplify the ligated portion of the
circles. We found that the procedure was robust when several parameters
were varied, including the molar ratio of the template to the collector
probe, ligation time and temperature, and the number of ligation cycles.
Data processing and analysis. The standard Illumina preprocessing
pipeline was carried out (21), and reads which passed default ﬁltering
weremappedusingMAQversion0.7.1withdefaultparameters(twomis-
matches per read permitted) (22). Typically 86 to 91% of the reads
mapped to the PAO1 genome. Reads per insertion location were tallied
usingcustomPerlscripts(availableuponrequest).Readswhichcouldnot
be mapped to an unambiguous location due to repetitive chromosomal
sequences(MAQmappingscoreofzero,fewerthan2%ofmappedreads)
were excluded from further analysis. In a few cases (fewer than 2% of
locations), polymerase slippage during sequencing appeared to cause
somereadstomaptonucleotidesadjacenttotheinsertionjunction.These
cases were recognizable as co-oriented reads mapping to adjacent nucle-
otides where the number of reads for one of the positions comprised a
small fraction of the number of reads for the adjacent position. In such
cases, all of the reads were considered to correspond to a single insertion
and were assigned to the position with the largest number of reads.
Read counts per gene were based on insertion locations in the central
80% of the ORF and were normalized to account for gene length, total
mapped reads per Tn-seq run, and local read density. The overall corre-
lation between gene length and number of insertion locations per gene
was83%,validatingtheuseofgenelengthasanormalizationfactor.Local
readdensitywascalculatedforeachinsertionlocationastheaveragenum-
ber of reads for positions within an approximately 100-kb window sur-
rounding that location whose read counts deviated from the overall aver-
age for the same window by no more than 2-fold. For each insertion
position, the number of reads at that position was normalized according
to its local read density relative to the average local read density for all
positions.Thisnormalizationwasnecessarybecausesomesamplesgrown
on tobramycin showed low relative density near the chromosomal repli-
cation origin and higher relative density near the terminus of replication,
while samples grown without tobramycin showed higher relative density
near the origin and lower relative density near the terminus. The overall
correction from raw read numbers was, at most, 3-fold. The complete
equation for normalization was as follows: normalized no. of reads per
gene(forinsertionlocationsincentral80%ofORF)[rawreadcounts
 (average read density/local read density)]  107/[gene length  total
no. of mapped reads per run]. For determination of negative selection,
geneswithfewerthanthreemappedinsertionlocationsinthemiddle80%
of the ORF were excluded, as were genes which showed 67% loss of
representation after growth in the absence of tobramycin (based on read
countsaftergrowthrelativetothosebeforegrowth).Somegenes(33/150)
were also excluded if manual examination of the distribution of hits and
reads within the ORF betrayed questionable evidence of negative selec-
tion, even though the strict numerical criteria were satisﬁed. Examples
included genes with few (though at least three) insertion locations or
genes with very low read numbers at almost all sites, such that excessive
reads at a single location skewed the calculated degree of negative selec-
tion.
Nucleotide sequence accession numbers. The Illumina sequencing
reads listed in Table 1 have been deposited in the NCBI Sequence Read
Archive (http://www.ncbi.nlm.nih.gov/sra) under accession number
SRA026588.
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